Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesUnder-reporting of compensable mesothelioma in Alberta
American Journal of Industrial Medicine, 06/09/09
Cree MW et al. - Patient under-reporting of compensable mesothelioma is a problem and raises larger questions regarding under-reporting of other asbestos-related cancers in Alberta. Strategies should focus on increasing filing rates where appropriate.
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology, 10/19/09
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09
Today in Occupational Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: a Multicenter Study in Europe
Occupational and Environmental Medicine, 10/13/09
The additive value of patch testing with patients own products at an occupational dermatology clinic
Contact Dermatitis, 10/28/09
1,3-Butadiene, Styrene and Lung Cancer Among Synthetic Rubber Industry Workers
Journal of Occupational and Environmental Medicine, 10/28/09
Sponsor
Article Search
Sponsor